Transgenic mice with miRNA122a knockout have been shown to spontaneously develop HCC with the miRNA122a −/− tumor cells showing increased expression of CSC markers such as EpCAM, CD90 and CD133 [31]. The gene discussed is EPCAM; the disease is hepatocellular carcinoma.